Leitch HA - Search Results

1

Supportive care and chelation therapy in MDS: are we saving lives or just lowering iron?

Leitch HA, Vickars LM. Leitch HA, et al. Hematology Am Soc Hematol Educ Program. 2009:664-72. doi: 10.1182/asheducation-2009.1.664. Hematology Am Soc Hematol Educ Program. 2009. PMID: 20008252 Review.

2

Aplastic anemia following administration of a tumor necrosis factor-alpha inhibitor.

Kuruvilla J, Leitch HA, Vickars LM, Galbraith PF, Li CH, Al-Saab S, Naiman SC. Kuruvilla J, et al. Among authors: leitch ha. Eur J Haematol. 2003 Nov;71(5):396-8. doi: 10.1034/j.1600-0609.2003.00115.x. Eur J Haematol. 2003. PMID: 14667206

3

Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: a report of two cases.

Lester R, Li C, Phillips P, Shenkier TN, Gascoyne RD, Galbraith PF, Vickars LM, Leitch HA. Lester R, et al. Among authors: leitch ha. Leuk Lymphoma. 2004 Sep;45(9):1881-5. doi: 10.1080/10428190410001697395. Leuk Lymphoma. 2004. PMID: 15223650

4

Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis.

Fung SS, Hillier KL, Leger CS, Sandhu I, Vickars LM, Galbraith PF, Li CH, Leitch HA. Fung SS, et al. Among authors: leitch ha. Leuk Lymphoma. 2007 Jun;48(6):1087-91. doi: 10.1080/10428190701321277. Leuk Lymphoma. 2007. PMID: 17577771

5

Improved survival in HIV-associated diffuse large B-cell lymphoma with the addition of rituximab to chemotherapy in patients receiving highly active antiretroviral therapy.

Ezzat H, Filipenko D, Vickars L, Galbraith P, Li C, Murphy K, Montaner JS, Harris M, Hogg RS, Vercauteren S, Leger CS, Zypchen L, Leitch HA. Ezzat H, et al. Among authors: leitch ha. HIV Clin Trials. 2007 May-Jun;8(3):132-44. doi: 10.1310/hct0803-132. HIV Clin Trials. 2007. PMID: 17621460

6

Improving clinical outcome in patients with myelodysplastic syndrome and iron overload using iron chelation therapy.

Leitch HA. Leitch HA. Leuk Res. 2007 Dec;31 Suppl 3:S7-9. doi: 10.1016/S0145-2126(07)70460-5. Leuk Res. 2007. PMID: 18037416 Review.

7

Acute leukemia in patients sixty years of age and older: a twenty year single institution review.

Leger CS, Leitch HA, Galbraith PF, Li CH, Vickars LM. Leger CS, et al. Among authors: leitch ha. Am J Clin Oncol. 2009 Apr;32(2):137-41. doi: 10.1097/COC.0b013e31818a6c93. Am J Clin Oncol. 2009. PMID: 19307947 Clinical Trial.

8

Improved survival in red blood cell transfusion dependent patients with primary myelofibrosis (PMF) receiving iron chelation therapy.

Leitch HA, Chase JM, Goodman TA, Ezzat H, Rollins MD, Wong DH, Badawi M, Leger CS, Ramadan KM, Barnett MJ, Foltz LM, Vickars LM. Leitch HA, et al. Hematol Oncol. 2010 Mar;28(1):40-8. doi: 10.1002/hon.902. Hematol Oncol. 2010. PMID: 19557769

9

Red blood cell transfusion independence following the initiation of iron chelation therapy in myelodysplastic syndrome.

Badawi MA, Vickars LM, Chase JM, Leitch HA. Badawi MA, et al. Among authors: leitch ha. Adv Hematol. 2010;2010:164045. doi: 10.1155/2010/164045. Epub 2010 Mar 23. Adv Hematol. 2010. PMID: 20368773 Free PMC article.

10

Controversies surrounding iron chelation therapy for MDS.

Leitch HA. Leitch HA. Blood Rev. 2011 Jan;25(1):17-31. doi: 10.1016/j.blre.2010.09.003. Epub 2010 Oct 27. Blood Rev. 2011. PMID: 21030120 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page